FDA offers Roche an emergency OK for coronavirus testing tech — easing a critical logjam
As criticism of the slow-motion response to provide ample numbers of tests to identify the spread of coronavirus in the US and Europe mounts, the FDA has rushed through an OK of a new test from Roche that has the capacity to significantly amp up the process.
Using its emergency powers, Bloomberg reports, the agency has cleared tests using Roche’s cobas 6800/8800, with the 8800 able to test more than 4,000 patients a day.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 76,800+ biopharma pros reading Endpoints daily — and it's free.